Home
>
US Stocks
>
Frequency Therapeutics Inc
Frequency Therapeutics Inc
FREQ

Frequency Therapeutics Inc

$6.8611.37%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.79
Today Low/High
6.73 / 6.88
52 Week Low/High
$6.86 / $58.37
Market Cap
$257.44M

Company Details

Frequency Therapeutics is a leader in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The Company's progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. The Company's lead product candidate, FX-322, is designed to regenerate auditory hair cells to restore hearing function. FX-322 is being evaluated in multiple ongoing clinical studies in patients with sensorineural hearing loss. The Company also is evaluating additional diseases where its PCA approach could create functional tissue, including in a pre-clinical program in multiple sclerosis.
Organisation
Frequency Therapeutics Inc
Employees
85
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Frequency Therapeutics Inc share price today

Can Indians buy Frequency Therapeutics Inc shares?

How can I buy Frequency Therapeutics Inc shares from India?

Can Fractional shares of Frequency Therapeutics Inc be purchased?

What are the documents required to start investing in Frequency Therapeutics Inc stocks?

We are a SEBI registered investement advisor